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Abstract
Background: Marker chromosomes are small supernumerary chromosomes that cannot be unambiguously identified
by chromosome banding techniques alone. However, the precise characterization of marker chromosomes is important
for prenatal diagnosis and proper genetic counseling. In this study, we evaluated the chromosomal origin of marker
chromosomes using a combination of banding cytogenetics and molecular cytogenetic techniques including diverse
fluorescence in situ hybridization (FISH) assays and array comparative genomic hybridization (array CGH).
Results: In a series of 2871 patients for whom cytogenetic analysis was requested, 14 cases with small supernumerary
marker chromosomes (sSMCs) were identified. Nine sSMCs were mosaic, and five nonmosaic. Of the nine cases with
known parental origins, four were identified as de novo, and four and one were maternally and paternally inherited,
respectively. Six sSMCs were identified by FISH using centromeric probes; three sSMCs were derived from chromosome
15, including two heterochromatic sSMC(15)s and a large sSMC(15) spanning 15q11.1q13.1, and three sSMCs originated
from chromosome 14 or 22. Array CGH revealed two cases with derivatives of chromosome 2 and whole chromosome
painting multicolor-FISH (M-FISH) identified three cases with derivatives of chromosome 6, 16, and 19, respectively.
One maker chromosome in Turner syndrome was characterized as sSMC(X) by preferential application of a
centromeric probe for X-chromosome. In addition, one sSMC composed of genomic materials from chromosomes 12
and 18 was identified in parallel with parental karyotype analysis that revealed the reciprocal balanced translocation.
Conclusions: This report is the largest study on sSMCs in Korea and expands the spectrum of sSMCs that are
molecularly characterized.
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Background
Marker chromosomes, also known as small supernumerary
marker chromosomes (sSMCs), are structurally abnormal
chromosomes that cannot be unambiguously identified or
characterized by conventional banding cytogenetics (ISCN
2013) [1]. They are generally equal or smaller in size than a
chromosome 20 of the same metaphase spread [2], and the
small size of markers precludes the identification of their
chromosomal origin by conventional banding techniques,
and molecular cytogenetic techniques are necessary for
their characterization.
According to a recent, comprehensive review [3],
marker chromosomes are found in 0.075 % of unselected
prenatal cases, and in 0.044 % of consecutive postnatal
cases, but frequencies are elevated to 0.125 % in infertile
subjects and to 0.255 % in developmentally retarded pa-
tients [3]. In terms of the parental origin of marker
chromosomes, approximately 30 % of markers are fa-
milial, while 70 % are de novo. The clinical phenotypes
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associated with marker chromosomes are also highly
variable, from normal to severely abnormal [4], and this
renders marker chromosomes a particularly difficult
problem in genetic counseling, especially in prenatal de
novo cases. There has been a previous report on marker
chromosomes identified in Korean patients [5] investi-
gated with fluorescence in situ hybridization (FISH) ana-
lysis, but with advancements in molecular cytogenetic
diagnostics, tools including whole-chromosome painting
FISH and array comparative genomic hybridization (array
CGH) have been applied in characterization of marker
chromosomes.
Therefore, in this study, we aimed to characterize con-
secutive marker chromosomes identified from a single
genetic center in Korea, with multiple molecular cyto-
genetic methods in combination with banding cytogen-
etics, to accurately characterize the chromosomal origin
and the genetic content of marker chromosomes.
Methods
Chromosomal analysis, referred for constitutional abnor-
mality, was performed on 2871 patients (1974 peripheral
blood specimens, 897 amniotic fluid specimens) from
January 2010 to December 2013 at Seoul St. Mary’s Hos-
pital. Written informed consent was obtained from the
patients and/or their family members. Whenever avail-
able, the familial occurrence of markers was evaluated
through parental studies. Information on the phenotypic
features of the patients was obtained by a review of med-
ical records. This study was conducted in accordance
with the ethical guidelines of the Declaration of Helsinki
and was approved by the Institutional Review Board
(IRB)/Ethics Committee of Seoul St. Mary’s Hospital
(IRB No.KC11TISI0277).
Banding cytogenetics
Banding cytogenetics was performed on G-banded meta-
phase chromosomes of cultured peripheral blood lympho-
cytes and/or amniotic fluid cells using routine techniques.
Karyotypes were interpreted according to the ISCN 2013.
FISH studies
If the size of the marker chromosome is similar to a
chromosome 20 of the same metaphase spread, FISH ana-
lysis using centromeric probes for chromosomes 15, 18,
and 12 was performed. If the size of the marker is smaller
than a chromosome 20, FISH analysis using centromeric
probes for all acrocentric chromosomes 15, 13/21, and 14/
22 was performed. In Turner syndrome (TS) patients with
a marker chromosome (45,X/46,X,+mar), FISH studies
using X centromeric probe as well as SRY were performed.
And in all patients with marker chromosomes, parental
study was performed in parallel, whenever possible. The
FISH probes used in this study are summarized in
Additional file 1: Table S1.
If the origin of the marker chromosome was not clari-
fied by the above strategies, we then performed whole
chromosome painting multicolor-FISH (M-FISH) and/or
array CGH, based on the level of mosaicism, and the
amount of specimen available. M-FISH was performed
using the 24 XCyte Human Multicolor FISH Probe kit
(MetaSystems, Altlussheim, Germany) according to the
manufacturer’s instructions. Fluorescent images were
captured and analysed using an Axio Imager 2 fluores-
cence microscope (Zeiss, Jena, Germany) and Isis image
analysis software (MetaSystems).
Array CGH
Array CGH analysis was performed using a SurePrint G3
Human CGH Microarray 8 X 60 K kit (Agilent Technolo-
gies, Santa Clara, CA, USA), which consisted of 62,976
oligonucleotide probes spaced at 41 kbp intervals (median
probe spacing) throughout the genome. Control DNA
(Promega Corp., Nepean, Canada) was used as the refer-
ence DNA. DNA digestion, labeling and hybridization
were performed following the manufacturer’s instructions.
Scanned images were quantified using Agilent Feature
Extraction software (v10.0), and the resulting data were
imported into Agilent Genomic Workbench 7.0.4.0
software for visualization, and copy number variations
were detected using the Aberration Detection Method-
2 (ADM-2) algorithm. All genomic coordinates were
based on human genome build hg19/GRCh37.
Results
Of 2871 patients referred for chromosomal analysis,
marker chromosomes were identified in 14 patients. Par-
ental study was performed in nine patients, and five
marker chromosomes (55.6 %) were inherited from one
of the parents, while four markers (44.4 %) were de novo.
Of the five inherited markers, four (80 %) were mater-
nally inherited and only one (20 %) was paternally inher-
ited. Mosaicism was detected in nine patients (64 %),
whereas a single cell line was observed in the remaining
five patients (36 %). Three marker chromosomes (21 %)
were equal in size to a chromosome 20, whereas the
other 11 (79 %) were smaller than a chromosome 20 of
the same metaphase spread. Although the depth of clin-
ical information available differed among the subjects,
most postnatal cases (10/11, 91 %) showed abnormal
phenotypes of variable severity (Table 1). All three pre-
natal cases were referred for advanced maternal age, and
in two cases parental study was available, and one was
maternally inherited and one de novo, and the outcome
of the pregnancies could not be followed up.
In the present study, chromosomal origins were identi-
fied in 13 of 14 identified marker chromosomes, and in
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one case, further characterization was not possible be-
cause there was not enough material. These marker chro-
mosomes originated from various chromosomes and
consisted of three cases (23 %) with derivatives of chromo-
some 15, two cases (15 %) with derivatives of chromosome
2, and one case (8 %) each with derivatives of chromo-
some 6, 14, 16, 19, 22, 14/22 and der(12;18)(p10;p10).
Also, in a patient with TS (45,X/46,X,+mar), the marker
chromosome originated from the X chromosome.
In accordance with the presented approach for marker
chromosome characterization, preferential application of
a centromeric probe specific for X- and Y-chromosome
identified the marker as mar(X) in a TS patient (Fig. 1).
And for an inherited marker chromosome (case 2), the
identification of a balanced translocation in one of the
parents led to a straightforward characterization of the
marker chromosome as 47,XX,+der(12;18)(p10;p10)
(Fig. 2).
The three marker chromosomes equal in size to a
chromosome 20 (cases 3, 4 and 5) were all derived from
chromosome 15, and this was readily identified by FISH
analysis using centromeric probes for chromosome 15.
FISH with centromeric probes for chromosome 12, and 18
was also performed to identify i(12p) associated with
Pallister-Killian (OMIM 601803) syndrome and i(18p) syn-
drome, respectively, but no i(12p) nor i(18p) was found in
this study. For both sSMC(15)s of case 3 and 4, FISH
analysis using probe D15S11(15q11.2) lacked a positive
hybridization signal and were therefore considered as
heterochromatic (Fig. 3a-d). However, in sSMC(15) of case
5, array CGH showed a 8.4 Mb gain of chromosome
15q11.1q13.1 (chr15:20,102,541-28,525,460) encompassing
ATP10A, CYFIP1, GABRA5, GABRB3, GABRG3, HERC2,
MAGEL2, MKRN3, NDN, NIPA1, NIPA2, OCA2, POTEB,
SNRPN, TUBGCP5, and UBE3A genes, with a log2 ratio of
1.0409, inherited from a phenotypically normal mother
(Fig. 3e). For the marker chromosomes smaller than that
of a chromosome 20, FISH analysis using centromeric
probes for all acrocentric chromosomes was performed se-
quentially according to their reported frequency in the lit-
erature, starting with chromosome 15, followed by 14/22
and 13/21. This led to the characterization of three cases
that originated from chromosome 14 and/or 22 (Fig. 4).
Therefore, in a total of six cases, the chromosomal origin
of the marker chromosome was ascertained by FISH
probes targeting the centromere.
For the remaining five marker chromosomes, M-FISH
and/or array CGH identified the chromosomal origin. Two
cases with a marker originating from chromosome 2 were
characterized by array CGH. Array CGH detected a mater-
nally inherited gain of 12.6 Mb derived from chromosome
2q11.1q12.3 (chr2: 95,529,039-108,083,956) with a log2ratio
of 0.4890 and a de novo 5.7 Mb loss of chromosome
18p11.32p11.31 (chr18: 142,096-5,853,122) with a log2 ratio
of -0.8833 in case 12 (Fig. 5a-b). A de novo 9.8 Mb gain of
chromosome 2q11.1q12.1 (chr2: 95,529,039-105,358,887)
with a log2 ratio of 0.3365 and maternally inherited 1.4 Mb
gain of chromosome 7q11.23 (chr7: 72,726,578-74,139,390)
with a log2 ratio of 0.4710 were identified in case 13
(Fig. 5c-e). Further FISH analysis confirmed that the 2q-
amplified region, detected by array CGH, was localized to
the marker chromosomes (Fig. 6). Three cases with
low-level mosaicism were evaluated with M-FISH and
the origin of the sSMCs was chromosome 6, 16 and 19,
respectively (cases 9, 10 and 11) (Fig. 7).
On the basis of our experience, the present knowledge
of sSMC frequency [5] and the previously suggested
characterization schemes [6–8], we have followed a modi-
fied algorithm that allowed the determination of the
chromosomal origin of the marker chromosome in an ef-
fective manner using diverse techniques including band-
ing cytogenetics, M-FISH and array CGH (Fig. 8).
Fig. 1 a Karyotype of the patient with Turner syndrome; b Interphase FISH analysis using the probes of DXZ (Xp11.1-q11.1; spectrum green) and
SRY (Yp11.31; spectrum red) probes shows two copies of green and absence of red signals
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Fig. 2 a Karyotype of the patient’s father showing 46,XY,t(12;18)(p10;p10); b M-FISH analysis demonstrated that sSMC was structured from
chromosome 12 and 18 in case 2
Fig. 3 Identification of the chromosomal origin of the sSMC(15) by FISH and array CGH. a FISH analysis using D15Z1 (15p11.2; spectrum red)
probe shows a red hybridization signal on the marker chromosome (case 3); b-c FISH analysis of the idic(15) using D15Z1 (15p11.2; spectrum
green) and D15S11 (15q11-q13; spectrum red). sSMCs have two green hybridization signals of D15Z1 with no D15S11 signal (case 3, B; case 4, C);
d SMC(15) identified with M-FISH 15 (case 4); e Array CGH analysis results showing amplification from 15q11.1 to 15q13.1 (chr15: 20,102,541-28,525,460),
spanning 8.4 Mb (case 5)
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Discussion
In our study population, six (6/12, 50 %) marker chro-
mosomes were derived from acrocentric autosomes, six
were derived from non-acrocentric autosomes and one
from the X chromosome. Marker chromosome derived
from chromosome 15 was the most frequent sSMC
identified in individuals with karyotype 47,XN,+mar (3/
12, 25 %), similar to the reported frequency of 30 % in
the literature [8]. In the present study, 2 sSMC(15)s were
without euchromatin, but 1 sSMC(15) showed a mater-
nally inherited euchromatic sSMC(15) spanning 15q11.1
to 15q13.1. Larger sSMC(15) with euchromatic content
has been associated with a wide spectrum of clinical fea-
tures from normal to full phenotype of the 15q11-q13
duplication syndrome (OMIM #608636) including aut-
ism, mental retardation, ataxia, seizures, developmental
delays, and behavioral problems [9, 10], and generally,
sSMC(15) spanning 15pter to 15q12 tend to have less
severe phenotype than larger ones including 15pter to
15q14. While the identical large sSMC(15) was also
identified in her phenotypically normal mother, the
mother had a mosaic sSMC(15) (mos 47,XX,+mar[37]/
46,XX[3]) while the proband had a single cell line, sug-
gesting that the lack of mosaicism may be associated
with the abnormal phenotype seen in the proband.
FISH analysis using centromeric probes for 14/22, con-
firmed three sSMCs as derived from chromosome 14 or
22. Following M-FISH analysis, two cases were identified
as sSMC(14) and sSMC(22), respectively. However, the
sSMC of case 8 was not resolved by M-FISH. This may be
due to an underrepresentation of the region in M-FISH
probes or a “flaring effect” of the fluorescence-intense
centromeric signal [11]. The presence of a sSMC(14) is
very rare [12] and among sSMC(14) cases with clinical
signs, dysmorphic features and mental retardation are
most often reported [8]. Regarding sSMC(22), 70 % of
Fig. 4 M-FISH analysis profiles of sSMC(14) or sSMC(22). a The marker contained chromosome 14 material (case 6); b The dicentric marker
contained chromosome 22 material (case 7); c FISH analysis of the sSMC using an alpha satellite probe D14Z1/D22Z1, cep14/22 (spectrum red)
showing positive hybridization signals on two chromosomes 14, two chromosomes 22 and the marker chromosome. M-FISH could not distinguish
between chromosome 14 and chromosome 22 (case 8)
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carriers are clinically normal [13] but distinct pathologic
phenotypes, including CES (cat-eye syndrome, OMIM
#115470) and ES (Emanuel syndrome, OMIM #609029)
are associated with sSMC(22). The majority of CES is
caused by bisatellited isodicentric marker chromosome
containing CES critical region located in the most
proximal 2-2.5 Mb of 22q11 [14] and ES is most often
caused by a balanced translocation, t(11;22)(q23;q11.2), in
one of the parents. Case 7 had an extra dicentric chromo-
some 22, however, analysis for CES critical region could
not be done due to the insufficient amount of specimen.
Furthermore, we were unable to obtain detailed clinical
Fig. 5 Array CGH analysis profiles of sSMC(2)s. a Array CGH detected a gain of 12.6 Mb derived from chromosome 2q11.1q12.3 (chr2:95,529,039-
108,083,956) (case 12); b Identical duplication shown in her mother; c De novo 9.8 Mb gain of chromosome 2q11.1q12.1 (chr2: 95,529,039-
105,358,887) (case 13). d-e Genomic microarray ratio plots for chromosome 2 showing no imbalances in both father (d) and mother (e) of case 13
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information regarding the presence or absence of major
CES phenotypes including ocular coloboma, anal atresia,
and renal malformations.
Marker chromosomes derived from non-acrocentric au-
tosomes comprise about 40 % of all markers among indi-
viduals with karyotype 47,XN,+mar, and the risk of an
abnormal phenotype associated with non-acrocentric au-
tosomes is approximately 28 % [8, 15, 16]. In our study,
five cases (5/12, 42 %) were derived from non-acrocentric
autosomes and had clinical features of developmental
delay or short stature, with the exception of case 9 for
whom phenotypic information was not available. Two
ring-shaped marker chromosomes were characterized by
array CGH as originating from chromosome 2q. The ma-
jority of previously reported sSMC(2)s are ring-shaped
sSMCs, as in this study, and a correlation of 2p11.2 with
the presence of clinical abnormalities, and 2q11.2 with an
absence of clinical signs have been suggested [17]. For
Fig. 6 Identification of the chromosomal origin of the sSMC(2) by FISH in case 13. FISH analysis with MYCN (2p24,3; spectrum red) probe and
LAF4 (2q11.2; spectrum green) probe shows a green hybridization signal on the marker chromosome, indicating that it is a derivative of
chromosome 2 (a). No red signal was observable on any structure other than normal homologues of chromosome 7 using FISH analysis with the
probes of ELN (7q11.23; spectrum red) and D7S485/D7S522 (7q31; spectrum green) (b)
Fig. 7 Two sSMCs were characterized using multicolor FISH (M-FISH), which demonstrated the presence of additional material that originated
from chromosome 16 (a, case 10) and 19 (b, case 11)
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case 12, we have assumed that the sSMC(2) was maternal
in origin so the sSMC itself is harmless. However, for case
13, in addition to the sSMC(2), a duplication of 7q11.23
was identified by array CGH, and the genotype-phenotype
correlation of sSMC(2) was not evident for this case.
Marker chromosomes derived from non-acrocentric auto-
somes such as chromosome 6, 16, and 19 are also very
rare (0.6–1.4 %) and the phenotype associated with each
marker is not well established [6].
Marker chromosomes are found in 7-16 % of patients
with TS and the marker chromosome is mainly from sex
chromosomes, and only rarely from autosomes [18].
Screening of Y chromosome material in sSMC of TS
patients is important because of its associated risk of
gonadoblastoma [19]. Also, when sSMC is derived from
X chromosome in TS patients, depending on the size
and content of the sSMC(X)s, lack of the XIST locus
(Xq13.2) may be associated with a more severe pheno-
type that includes mental retardation [18]. Although we
did not perform FISH for the XIST gene, case 1 had no
mental retardation, suggesting that her sSMC(X) con-
tained XIST.
The extra derivative chromosome produced by the ex-
change of genomic material between two or more chro-
mosomes is also very rare, except in ES. As shown in
our case, parental karyotyping becomes relevant in tra-
cing the origins of sSMCs. To our knowledge, this is the
first reported case associating derivative marker chromo-
some involving chromosome 12 and 18. This patient
with trisomy 12p and trisomy 18p showed incomplete
cleft palate, developmental coordination disorder and
development delay.
There are only a few well-established clinical syndromes
associated with sSMCs originating from chromosomes 12,
15, 18 and 22 [20]. And the clinical outcome of the major-
ity of marker chromosomes is highly variable, depending
on their origin, size, euchromatin content, co-occurrence
of uniparental disomy, and prevalence of aneuploidy in
mosaic cases [21]. Generally, while there is no discernibly
increased risk for fetal abnormalities if the marker has
been inherited from a phenotypically normal parent, the
risk for an abnormal phenotype in prenatally ascertained
de novo cases is given as ~13 % [22]. Therefore the clinical
management and genetic counseling depend on the char-
acteristics of marker chromosomes and parental origin. In
this regard, molecular cytogenetics, in combination
with banding cytogenetics can provide precise informa-
tion of the breakpoints of the marker chromosomes
and accurate delineation of chromosomal content. The
algorithm followed in this study proved as a straightfor-
ward and efficient strategy that can be used in most
diagnostic molecular cytogenetic laboratories for
characterization of sSMCs. Using this algorithm acro-
centric sSMCs can be characterized in 2 days, and non-
acrocentric sSMCs requiring M-FISH or array CGH
can be characterized in 5 days.
Conclusion
This report is the largest study on sSMCs in Korea and ex-
pands the spectrum of sSMCs that are molecularly charac-
terized. The stepwise application of molecular cytogenetic
methods proved as both practical and efficient strategy that
allowed straightforward and accurate characterization of
sSMCs. And an accurate identification of the genetic
Fig. 8 The algorithm for the determination of chromosomal origin of marker chromosomes
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content of sSMCs should provide more information on
genotype-phenotype correlation and for genetic counseling.
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